Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands (2019) Haller F, Bieg M, Will R, Koerner C, Weichenhan D, Bott A, Ishaque N, et al. Journal article MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies (2018) Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, et al. Conference contribution Successful Long-term Treatment of Diversion Colitis with Topical Coconut Oil Application (2018) Zundler S, Dietz L, Matzel KE, Geppert CI, Becker E, Rath T, Neurath M, Atreya R Journal article, Letter Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment (2018) Belaloui K, Malifarge E, Bohm J, Bossard C, Dienstmann R, Garcia S, Geppert CI, et al. Conference contribution A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients (2018) Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, et al. Conference contribution Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes (2018) Fisel P, Buettner F, Reustle A, Klumpp V, Winter S, Rausch S, Hennenlotter J, et al. Conference contribution Potential biomarkers correlated with poor survival rate of melanoma patients (2018) Morais AS, Monteiro AC, Andrade F, Goedert L, Espreafico E, Schneider-Stock R, Fujiota A, Jasiulionis MG Conference contribution Targeting colorectal cancer stem cells with the anticancer molecule thymoquinone (2018) Ballout FR, Fatfat M, Abdel-Samad R, Darwiche N, Schneider-Stock R, Abou-Kheir W, Muhtasib HG Conference contribution Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness (2018) Böhm J, Muenzner JK, Caliskan A, Ndreshkjana B, Erlenbach-Wunsch K, Merkel S, Croner RS, et al. Conference contribution Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients (2018) Hübner H, Fasching P, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, et al. Journal article